ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain

Matrix Biology

Volumn 28, Issue 3, 2009, Pages 160-169

  Sercu, S ^a   Lambeir, A M ^a   Steenackers, E ^a   El Ghalbzouri, A ^b   Geentjens, K ^a   Sasaki, T ^c   Oyama, N ^d   Merregaert, J ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Binding partners; Extracellular matrix protein 1; Fibulin 3; Laminin 332; Yeast two hybrid

Indexed keywords

EXTRACELLULAR MATRIX PROTEIN 1; FIBULIN; FIBULIN 3; KALININ; SCLEROPROTEIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA CHAIN; DNA LIBRARY; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LIPOID PROTEINOSIS; PREPUCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SKIN;

AMINO ACID SEQUENCE; CELL ADHESION MOLECULES; CELL-FREE SYSTEM; CELLS, CULTURED; EPIDERMIS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; IMMUNOPRECIPITATION; KERATINOCYTES; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SERUM ALBUMIN; SKIN; TWO-HYBRID SYSTEM TECHNIQUES; VITAMIN D-BINDING PROTEIN;

EID: 67349261476     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2009.02.003     Document Type: Article

References (42)

1. Albig A.R., Neil J.R., and Schiemann W.P. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res. 66 (2006) 2621-2629
2. Albig A.R., Roy T.G., Becenti D.J., and Schiemann W.I. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterisation of MAGP-2 and lumincan as novel regulators of angiogenesis. Angiogenesis 10 3 (2007) 197-216
3. Argraves W.S., Greene L.M., Cooley M.A., and Gallagher W.M. Fibulins: physiological and disease perspectives. EMBO Rep. 4 (2003) 1127-1131
4. Bates P.A., Kelley L.A., MacCallum R.M., and Sternberg M.J. Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins Suppl. 5 (2001) 39-46
5. Bhalerao J., Tylzanowski P., Filie J.D., Kozak C.A., and Merregaert J. Molecular cloning, characterization, and genetic mapping of the cDNA coding for a novel secretory protein of mouse. Demonstration of alternative splicing in skin and cartilage. J. Biol. Chem. 270 (1995) 16385-16394
6. Borradori L., Koch P.J., Niessen C.M., Erkeland S., van Leusden M.R., and Sonnenberg A. The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit. J. Cell Biol. 136 (1997) 1333-1347
7. Burgeson R.E., and Christiano A.M. The dermal-epidermal junction. Curr. Opin. Cell Biol. 9 (1997) 651-658
8. Chan I., Liu L., Hamada T., Sethuraman G., and McGrath J.A. The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1. Exp. Dermatol. 16 (2007) 881-890
9. Claes K.G., Claes L.R., Van Goethem J.W., Sercu S., Merregaert J., Lambert J., Van Marck E.A., Parizel P.M., and De Jonghe P. Epilepsy and migraine in a patient with Urbach-Wiethe disease. Seizure 16 (2007) 465-468
10. Deckers M.M., Smits P., Karperien M., Ni J., Tylzanowski P., Feng P., Parmelee D., Zhang J., Bouffard E., Gentz R., Lowik C.W., and Merregaert J. Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone 28 (2001) 14-20
11. Fujimoto N., Terlizzi J., Brittingham R., Fertala A., McGrath J.A., and Uitto J. Extracellular matrix protein 1 interacts with the domain III of fibulin-1C and 1D variants through its central tandem repeat 2. Biochem. Biophys. Res. Commun. 333 (2005) 1327-1333
12. Fujimoto N., Terlizzi J., Aho S., Brittingham R., Fertala A., Oyama N., McGrath J.A., and Uitto J. Extracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactions. Exp. Dermatol. 15 (2006) 300-307
13. Ghalbzouri A.E., Gibbs S., Lamme E., Van Blitterswijk C.A., and Ponec M. Effect of fibroblasts on epidermal regeneration. Br. J. Dermatol. 147 (2002) 230-243
14. Giltay R., Timp R., and Costca G. Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. Matrix Biol. 18 5 (1999) 469-480
15. Godin R.E., Urry L.A., and Ernst S.G. Alternative splicing of the Endo16 transcript produces differentially expressed mRNAs during sea urchin gastrulation. Dev. Biol. 179 (1996) 148-159
16. Green K.J., and Jones J.C. Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J. 10 (1996) 871-881
17. Hamada T., McLean W.H., Ramsay M., Ashton G.H., Nanda A., Jenkins T., Edelstein I., South A.P., Bleck O., Wessagowit V., Mallipeddi R., Orchard G.E., Wan H., Dopping-Hepenstal P.J., Mellerio J.E., Whittock N.V., Munro C.S., van Steensel M.A., Steijlen P.M., Ni J., Zhang L., Hashimoto T., Eady R.A., and McGrath J.A. Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum. Mol. Genet. 11 (2002) 833-840
18. Hamada T., Wessagowit V., South A.P., Ashton G.H., Chan I., Oyama N., Siriwattana A., Jewhasuchin P., Charuwichitratana S., Thappa D.M., Jeevankumar B., Lenane P., Krafchik B., Kulthanan K., Shimizu H., Kaya T.I., Erdal M.E., Paradisi M., Paller A.S., Seishima M., Hashimoto T., and McGrath J.A. Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. J. Invest. Dermatol. 120 (2003) 345-350
19. Han Z., Ni J., Smits P., Underhill C.B., Xie B., Chen Y., Liu N., Tylzanowski P., Parmelee D., Feng P., Ding I., Gao F., Gentz R., Huylebroeck D., Merregaert J., and Zhang L. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J. 15 (2001) 988-994
20. Johnson M.R., Wilkin D.J., Vos H.L., Ortiz de Luna R.I., Dehejia A.M., Polymeropoulos M.H., and Francomano C.A. Characterization of the human extracellular matrix protein 1 gene on chromosome 1q21. Matrix Biol. 16 (1997) 289-292
21. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan. Med. Bull. 37 (1990) 57-84
22. Marinkovich M.P., Keene D.R., Rimberg C.S., and Burgeson R.E. Cellular origin of the dermal-epidermal basement membrane. Dev. Dyn. 197 (1993) 255-267
23. Mathieu E., Meheus L., Raymackers J., and Merregaert J. Characterization of the osteogenic stromal cell line MN7: identification of secreted MN7 proteins using two-dimensional polyacrylamide gel electrophoresis, western blotting, and microsequencing. J. Bone Miner. Res. 9 (1994) 903-913
24. Mongiat M., Fu J., Oldershaw R., Greenhalgh R., Gown A.M., and Iozzo R.V. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis. J. Biol. Chem. 278 (2003) 17491-17499
25. Mongiat M., Sweeney S.M., San Antonio J.D., Fu J., and Iozzo R.V. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278 (2003) 4238-4249
26. Oyama N., Chan I., Neill S.M., Hamada T., South A.P., Wessagowit V., Wojnarowska F., D'Cruz D., Hughes G.J., Black M.M., and McGrath J.A. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 362 (2003) 118-123
27. Oyama N., Chan I., Neill S.M., South A.P., Wojnarowska F., Kawakami Y., D'Cruz D., Mepani K., Hughes G.J., Bhogal B.S., Kaneko F., Black M.M., and McGrath J.A. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J. Clin. Invest. 113 (2004) 1550-1559
28. Pai G.S., Vinod V., and Joshi A. Efficacy of erbium YAG laser-assisted autologous epidermal grafting in vitiligo. J. Eur. Acad. Dermatol. Venereol. 16 (2002) 604-606
29. Ponec M., Weerheim A., Kempenaar J., Mulder A., Gooris G.S., Bouwstra J., and Mommaas A.M. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J. Invest. Dermatol. 109 (1997) 348-355
30. Rousselle P., Lunstrum G.P., Keene D.R., and Burgeson R.E. Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J. Cell Biol. 114 (1991) 567-576
31. Sercu S., Zhang M., Oyama N., Hansen U., Ghalbzouri A.E., Jun G., Geentjens K., Zhang L., and Merregaert J. Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. J. Invest. Dermatol. 128 6 (2008) 1397-1408
32. Sercu S., Zhang L., and Merregaert J. The extracellular matrix protein 1: its molecular interaction and implication in tumor progression. Cancer Investig. 26 4 (2008) 375-384
33. Siebert M., Markowitsch H.J., and Bartel P. Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 126 (2003) 2627-2637
34. Smith F. The molecular genetics of keratin disorders. Am. J. Clin. Dermatol. 4 (2003) 347-364
35. Smits P., Ni J., Feng P., Wauters J., Boutaibi M.E., Dillon P.J., and Merregaert J. The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Genomics 45 (1997) 487-495
36. Smits P., Poumay Y., Karperien M., Tylzanowski P., Wauters J., Huylebroeck D., Ponec M., and Merregaert J. Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. J. Invest. Dermatol. 114 (2000) 718-724
37. Teive H.A.G., Pereira E.R., Zavala J.A.A., Lange M.C., de Paola L., Raskin S., Werneck L.C., Hamada T., and McGrath J.A. Generalized dystonia and striatal calcifications with lipoid proteinosis. Neurology 63 (2004) 2168-2169
38. Timpl R., Sasaki T., Kostka G., and Chu M.L. Fibulins: a versatile family of extracellular matrix proteins. Nat. Rev. Mol. Cell. Biol. 4 (2003) 479-489
39. Uitto J. Elastic fibre abnormalities in skin disorders: what's new?. J. Eur. Acad. Dermatol. Venereol. 15 (2001) 303-304
40. Uitto J., and Pulkkinen L. Molecular complexity of the cutaneous basement membrane zone. Mol. Biol. Rep. 23 (1996) 35-46
41. Urbach E.W.C. Lipoidosis cutis et mucosae. Virchows Arch. Pathol. Anat. 273 (1929) 285-319
42. Van Hougenhouck-Tulleken W., Chan I., Hamada T., Thornton H., Jenkins T., McLean W.H., McGrath J.A., and Ramsay M. Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa. Br. J. Dermatol. 151 (2004) 413-423